Objective To investigate the efficacy and safety of single-or double-drug cytotoxic regimens as second-line treatment of......

目的：评价FOLFIRI方案二线治疗晚期胃癌的疗效及不良反应。方法23例晚期胃癌患者采用伊立替康150 mg/m2,静脉滴注90 min, d1；甲酰四......